Mental Health Screening Market Introduction and Overview
According to SPER Market Research, the Global Mental Health Screening Market is estimated to reach USD 2.88 billion by 2033 with a CAGR of 12.43%.
The report includes an in-depth analysis of the Global Mental Health Screening Market, including market size and trends, product mix, applications, and supplier analysis. A mental health screening involves answering a series of standard questions to help a healthcare provider determine whether a patient is showing symptoms of a mental illness. The healthcare provider can learn vital information about the patient's current state of mind, thinking, behaviour, and memory with the use of the questionnaire. Early detection of mental health issues can be achieved by mental health screening. In the event that the screening reveals symptoms of a disorder, more testing is required to confirm the diagnosis. Mental health screenings come in several forms. While some focus on generic symptoms of the most prevalent mental health disorders, others check for symptoms unique to particular disorders.
- November 2023; Total Brain (US) was bought by SonderMind (US) in order to broaden its scope and provide tailored mental wellness, enhanced treatment approaches for therapists, demographic mental health tools for businesses, and all-inclusive health plan solutions.
- October 2023; Ellipsis Health, Inc. (US) collaborated with Augmedix (US) to provide automated mental health assessments at patient visits.
- December 2021; Quartet Health, Inc. (US) has successfully purchased InnovaTel Telepsychiatry (US), making its ambition of promptly bringing high-quality mental healthcare to everyone a reality.
Market Opportunities and Challenges
Technological developments have been a crucial factor in the market expansion for mental health screening. Additionally, the availability of online screening tools has made it simple for people to conduct screenings for mental health issues. Furthermore, advanced technologies like machine learning and artificial intelligence have raised the precision and efficacy of screening procedures. By utilizing the influence and reach of social media platforms, mental health screening tools and treatments can effectively reach and engage individuals. This can eventually improve care accessibility and promote early intervention for mental health illnesses.
One of the most serious issues confronting mental health screening methods and treatments is the uncertainty about their preciseness and reliability. The absence of uniform norms and validation procedures for mental health screening instruments is another issue that raises concerns. Inconsistent or erroneous data from screening technologies could result in false positives or false negatives if rigorous validation and testing processes aren't followed.
Market Competitive Landscape
The competitive environment in the mental health industry is rapidly changing, with new competitors and technology constantly entering the market. Several smaller enterprises and startups operate in the mental health industry, with a focus on discovering innovative new therapies and technology for mental health issues. They are frequently able to expand more promptly and adapt readily to changing market conditions. The major players in the Global AI-based Surgical Robots Market include: Adaptive Testing Technologies (US), Clarigent Health (US), Cognitive Health Solutions, LLC (US), Ellipsis Health Inc. (US), FuturesTHRIVE (US), Koninklijke Philips N.V. (Netherlands), Modern Life, Inc. (US), Quartet Health, Inc. (US), Thymia Limited (UK), Wellin5 USA Inc. (Canada), and others.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Indication, By Screening, By Technology, By Age Group
|
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
|
| Companies Covered | Adaptive Testing Technologies (US), Clarigent Health (US), Cognitive Health Solutions, LLC (US), Ellipsis Health Inc. (US), FuturesTHRIVE (US), Koninklijke Philips N.V. (Netherlands), Modern Life, Inc. (US), Quartet Health, Inc. (US), Thymia Limited (UK), Wellin5 USA Inc. (Canada), and others.
|
COVID-19 Impact on Global Mental Health Screening Market
There was a notable surge in the market during the COVID-19 pandemic. The infection caused a significant increase in the death rate. Millions of people also became impoverished and a number of people lost their jobs. These variables have a significant impact on people's mental health on a worldwide scale, which raised the prevalence of mental health issues. The market for mental health screenings expanded dramatically after COVID-19 as a result of people's growing awareness of mental health disorders. Additionally, some nations are spending money on hiring additional mental health specialists as well as advanced computing and telecom solutions.
Key Target Audience:
- Healthcare Providers
- Mental Health Professionals
- Pharmaceutical Companies
- Research Institutions
- Government Health Agencies
- Insurance Companies
- Technology Developers
- Employers
- Advocacy Groups
- Patient and Caregivers
Our in-depth analysis of the Mental Health Screening Market includes the following segments:
|
By Indication:
|
Depression
Bipolar
Schizophrenia
ADHD
Alzheimer
Dementia
|
|
By Screening:
|
Self
Interview
Observation
Biomarker
|
|
By Technology:
|
mHealth
Remote Platform
Telehealth
|
|
By Age Group:
|
Children & Adolescents (Age 0–18 Years)
Adults (Age 19–64)
Seniors (Age 65 and above)
|
Key Topics Covered in the Report:
- Global Mental Health Screening Market Size (FY’2024-FY’2033)
- Overview of Global Mental Health Screening Market
- Segmentation of Global Mental Health Screening Market By Indication (Depression, Bipolar, Schizophrenia, ADHD, Alzheimer, Dementia)
- Segmentation of Global Mental Health Screening Market By Screening (Self, Interview, Observation, Biomarker)
- Segmentation of Global Mental Health Screening Market By Technology (mHealth, Remote Platform, Telehealth)
- Segmentation of Global Mental Health Screening Market By Age Group (Children & Adolescents, Adults, Seniors)
- Statistical Snap of Global Mental Health Screening Market
- Expansion Analysis of Global Mental Health Screening Market
- Problems and Obstacles in Global Mental Health Screening Market
- Competitive Landscape in the Global Mental Health Screening Market
- Impact of COVID-19 and Demonetization on Global Mental Health Screening Market
- Details on Current Investment in Global Mental Health Screening Market
- Competitive Analysis of Global Mental Health Screening Market
- Prominent Players in the Global Mental Health Screening Market
- SWOT Analysis of Global Mental Health Screening Market
- Global Mental Health Screening Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Mental Health Screening Market
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Mental Health Screening Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Mental Health Screening Market
7. Global Mental Health Screening Market, By Indication (USD Million) 2020-2033
7.1. Global Mental Health Screening Market Size, Share and Forecast, By Indication, 2020-2026
7.2. Global Mental Health Screening Market Size, Share and Forecast, By Indication, 2027-2033
7.3. Depression
7.4. Bipolar
7.5. Schizophrenia
7.6. ADHD
7.7. Alzheimer
7.8. Dementia
8. Global Mental Health Screening Market, By Screening (USD Million) 2020-2033
8.1. Global Mental Health Screening Market Size, Share and Forecast, By Screening, 2020-2026
8.2. Global Mental Health Screening Market Size, Share and Forecast, By Screening, 2027-2033
8.3. Self
8.4. Interview
8.5. Observation
8.6. Biomarker
9. Global Mental Health Screening Market, By Technology (USD Million) 2020-2033
9.1. Global Mental Health Screening Market Size, Share and Forecast, By Technology, 2020-2026
9.2. Global Mental Health Screening Market Size, Share and Forecast, By Technology, 2027-2033
9.3. mHealth
9.4. Remote Platform
9.5. Telehealth
10. Global Mental Health Screening Market, By Age Group (USD Million) 2020-2033
10.1. Global Mental Health Screening Market Size, Share and Forecast, By Age Group, 2020-2026
10.2. Global Mental Health Screening Market Size, Share and Forecast, By Age Group, 2027-2033
10.3. Children & Adolescents (Age 0–18 Years)
10.4. Adults (Age 19–64)
10.5. Seniors (Age 65 and above)
11. Global Mental Health Screening Market Forecast, 2020-2033 (USD Million)
11.1. Global Mental Health Screening Market Size and Market Share
12. Global Mental Health Screening Market, By Region, 2020-2033 (USD Million)
12.1. Global Mental Health Screening Market Size and Market Share By Region (2020-2026)
12.2. Global Mental Health Screening Market Size and Market Share By Region (2027-2033)
11.3. Asia-Pacific
11.3.1. Australia
11.3.2. China
11.3.3. India
11.3.4. Japan
11.3.5. South Korea
11.3.6. Rest of Asia-Pacific
11.4. Europe
11.4.1. France
11.4.2. Germany
11.4.3. Italy
11.4.4. Spain
11.4.5. United Kingdom
11.4.6. Rest of Europe
11.5. Middle East and Africa
11.5.1. Kingdom of Saudi Arabia
11.5.2. United Arab Emirates
11.5.3. Qatar
11.5.4. South Africa
11.5.5. Egypt
11.5.6. Morocco
11.5.7. Nigeria
11.5.8. Rest of Middle-East and Africa
11.6. North America
11.6.1. Canada
11.6.2. Mexico
11.6.3. United States
11.7. Latin America
11.7.1. Argentina
11.7.2. Brazil
11.7.3. Rest of Latin America
13. Company Profile
13.1. Adaptive Testing Technologies (US)
13.1.1. Company details
13.1.2. Financial outlook
13.1.3. Product summary
13.1.4. Recent developments
13.2. Clarigent Health (US)
13.2.1. Company details
13.2.2. Financial outlook
13.2.3. Product summary
13.2.4. Recent developments
13.3. Cognitive Health Solutions, LLC (US)
13.3.1. Company details
13.3.2. Financial outlook
13.3.3. Product summary
13.3.4. Recent developments
13.4. Ellipsis Health Inc. (US)
13.4.1. Company details
13.4.2. Financial outlook
13.4.3. Product summary
13.4.4. Recent developments
13.5. FuturesTHRIVE (US)
13.5.1. Company details
13.5.2. Financial outlook
13.5.3. Product summary
13.5.4. Recent developments
13.6. Koninklijke Philips N.V. (Netherlands)
13.6.1. Company details
13.6.2. Financial outlook
13.6.3. Product summary
13.6.4. Recent developments
13.7. Modern Life, Inc. (US)
13.7.1. Company details
13.7.2. Financial outlook
13.7.3. Product summary
13.7.4. Recent developments
13.8. Quartet Health, Inc. (US)
13.8.1. Company details
13.8.2. Financial outlook
13.8.3. Product summary
13.8.4. Recent developments
13.9. Thymia Limited (UK)
13.9.1. Company details
13.9.2. Financial outlook
13.9.3. Product summary
13.9.4. Recent developments
13.10. Wellin5 USA Inc. (Canada)
13.10.1. Company details
13.10.2. Financial outlook
13.10.3. Product summary
13.10.4. Recent developments
13.11. Others
14. List of Abbreviations
15. Reference Links
16. Conclusion
17. Research Scope